varieti
method
routin
use
steril
medic
devic
use
hydrogen
peroxid
h
includ
vapor
plasma
gener
ioniz
mani
system
use
steril
valid
bioburden
reduct
use
bacteri
spore
explor
benefit
use
vapor
h
vhp
treatment
respir
emerg
decontamin
reus
allevi
ppe
shortag
healthcar
worker
emerg
factor
consid
effect
reus
respir
fit
filter
effici
decontaminationdisinfect
level
caus
viru
organ
concern
hospit
environ
methicillinresist
staphylococcu
aureu
clostridium
difficil
respir
process
vhp
ltsv
steri
mentor
oh
standard
steril
cycl
medic
devic
steril
assur
level
sal
requir
verifi
devic
surfac
use
biolog
indic
geobacillu
stearothermophilu
place
challeng
locat
packageload
treat
untreat
respir
test
filter
effici
ic
laboratori
brunswick
oh
use
abbrevi
test
protocol
ic
develop
niosh
precondit
hour
room
temperatur
qualit
fit
test
vhp
treat
respir
done
aerosol
saccharin
solut
per
osha
app
mgh
environment
health
safeti
volunt
previous
fit
type
respir
viral
infect
test
perform
biosafeti
level
nation
emerg
infecti
diseas
laboratori
neidl
propag
vero
cell
bei
resourc
niaid
nih
vero
african
green
monkey
kidney
work
bank
viru
stock
use
studi
passag
thrice
vero
cell
twice
cell
cell
maintain
dulbecco
modifi
eagl
medium
dmem
sodium
pyruv
thermofish
scientif
waltham
catalog
nonessenti
amino
acid
catalog
hifb
catalog
decontamin
sar
contamin
mask
use
vhp
respir
trim
cm
segment
along
outer
edg
ensur
layer
remain
intact
transfer
laboratori
appli
respir
segment
cover
approxim
half
outer
face
surfac
allow
air
dri
biosafeti
cabinet
bsc
approxim
hour
control
viru
appli
plastic
tissu
cultur
dish
catalog
one
expos
vhp
treatment
one
retain
ambient
temperatur
examin
effect
vhp
treatment
subsequ
contamin
set
respir
treat
vhp
follow
viru
applic
dri
group
repres
tabl
vhp
treatment
perform
use
steri
ft
room
sampl
expos
ppm
vapor
hydrogen
peroxid
approxim
hour
follow
offgass
hydrogen
peroxid
undetect
ppm
approxim
hour
total
initi
vhp
cycl
follow
vhp
exposur
respir
piec
ad
dmem
fb
antibioticsantimycot
vortex
rpm
minut
follow
centrifug
rcf
minut
viru
plastic
dish
resuspend
complet
dmem
infect
quantifi
use
plaqu
assay
duplic
use
undilut
eluat
dilut
addit
sampl
plate
duplic
cell
follow
incub
complet
dmem
ad
plate
observ
cytopath
effect
five
day
viru
titrat
plaqu
assay
sampl
dilut
dmem
hifb
antibioticantimycot
ad
confluent
monolay
vero
cell
duplic
sampl
adsorb
cell
monolay
h
co
gentl
rock
approxim
everi
minut
prevent
monolay
dri
monolay
overlaid
mix
microcrystallin
cellulos
carboxymethylcellulos
sodium
dupont
nutrit
bioscienc
wilmington
de
mix
modifi
eagl
medium
temin
modif
supplement
antibioticantimycot
glutamax
hifb
cell
incub
co
day
fix
neutral
buffer
formalin
remov
contain
stain
aqueou
gentian
violet
ricca
chemic
arlington
tx
neutral
buffer
formalin
min
rins
plaqu
enumer
respir
perform
test
vhp
cycl
compromis
filter
effici
respir
tabl
four
respir
pass
fit
test
human
subject
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
pass
sar
inactiv
face
mask
vhp
treatment
respir
intent
contamin
reduc
infecti
viru
load
limit
detect
log
calcul
base
volum
eluat
use
experi
premis
pfu
could
detect
assay
tabl
figur
plaqu
form
unit
sampl
treat
vhp
correspond
log
reduct
infecti
viru
load
compar
viru
stock
log
reduct
compar
infecti
viru
load
respir
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
studi
one
standard
cycl
vhp
steril
steri
ltsv
one
type
respir
found
feasibl
term
preserv
fit
filter
effici
return
respir
index
user
decontamin
reus
may
ensur
fit
longer
period
test
ongo
determin
fit
filter
effici
affect
multipl
decontamin
reus
cycl
vhp
system
provid
battel
memori
institut
http
sever
low
temperatur
steril
system
steri
http
obtain
emerg
use
author
applic
system
approv
use
decontamin
cycl
respect
one
concern
vhp
use
ga
steril
residu
may
build
respir
may
inhal
endus
detail
analysi
pentan
extract
respir
treat
vhp
salter
et
al
follow
predict
inhal
valu
compar
safeti
level
conclud
signific
threat
healthcar
worker
realist
scenario
least
one
cycl
concentr
time
hydrogen
peroxid
exposur
unit
test
design
steril
assur
level
reduct
geobacillu
stearothermophilu
spore
typic
process
valid
use
spore
applicationload
done
initi
regular
interv
system
verifi
chemic
indic
run
ltsv
system
setup
use
viral
infect
studi
valid
bacteri
spore
thu
h
exposur
condit
provid
bioburden
reduct
bacteri
spore
resist
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
microorgan
high
level
disinfect
also
common
clinic
pathogen
staphyloccoc
speci
c
difficil
expect
indic
fda
guidanc
entitl
enforc
polici
face
mask
respir
coronaviru
diseas
public
health
emerg
revis
april
document
fda
also
recommend
demonstr
viricid
activ
wherev
possibl
total
pfu
log
inocul
respir
treat
vhp
infecti
viru
could
detect
eluat
follow
treatment
includ
plaqu
assay
use
eluat
figur
plate
eluat
follow
monitor
cell
cytopath
effect
five
day
improv
sensit
result
suggest
vhp
treatment
effect
inactiv
pfu
load
onto
mask
x
pfu
could
elut
approxim
reduct
log
infect
due
combin
viral
inactiv
due
contact
respir
inabl
elut
infect
viru
respir
time
contact
tissu
cultur
flask
decreas
infect
similarli
suggest
recoveri
respir
fairli
effici
respir
laden
viru
vhp
treatment
respir
also
show
similar
amount
infect
viru
load
pfu
elut
respir
previou
treat
vhp
suggest
residu
respir
vhp
treatment
interf
viral
infect
limit
experi
static
applic
viru
respir
unlik
clinic
use
case
activ
air
flow
respir
via
inhal
healthcar
worker
may
enabl
penetr
aerosol
droplet
contain
viru
deeper
respir
studi
infect
viru
load
clinic
use
respir
determin
factor
consid
decontamin
methodolog
present
result
technic
bioburden
evalu
decontamin
method
respir
mani
consider
financi
logist
one
medic
institut
decid
decontamin
method
util
emerg
use
situat
result
present
meant
constitut
standalon
recommend
